See also our related blog for the Pediatric Preclinical Testing Initiative.

Friday, April 27, 2012

We are so proud of Lance

Congratulations to Lance Burrell, an undergraduate member of our rhabdomyosarcoma research team (back in the Capecchi lab days) who has graduated from Weber State University with a Master of Science in Radiological Sciences, Emphasis in Cardiology.  Lance has always been dedicated to patient care, and to have completed graduate school while working is an impressive accomplishment for Lance and his whole family.

Friday, April 20, 2012

MGH & Stanford


My thanks to hosts David Langenau at Massachusetts General Hospital and Lynn Million & Kristen Ganjoo at Stanford University, respectively, for the opportunities to present our sarcoma research to their Cancer Centers. The MGH talk highlighted exciting work by Jinu and Ken in our lab, whereas the Stanford talk highlighted separate work by Jinu and Lara.  It was a busy week of coast-to-coast travel, but well worth the scientific interactions.  The sarcoma research at each institution is superb.  

Friday, April 6, 2012

Fueling Osteosarcoma Research

Our sincere thanks to the Trey Foote Foundation and the graduating class of the International Air & Hospitality Academy in Vancouver, WA, who have raised funds for a research microscope.  This microscope will be used to study patient-derived primary tumor cell cultures from Vancouver-Portland area children, and dogs, with osteosarcoma.  The ultimate goal of this research is individualized, molecularly-targeted therapy for patients with osteosarcoma.

Trey's remarkable spirit is described here and can be seen tonight at 6:30pm PST on Portland tv station KATU.



[ Watch the KATU video here. ]

Monday, April 2, 2012

COG and AACR

The Children's Oncology Group meeting was March 27 - 30 in Minneapolis.  Presentations were given by Jinu on new targeted therapies for undifferentiated sarcomas, and an update of the DIPG preclinical consortium was given by Charles.  
  
The AACR meeting is now in progress, and beginning yesterday with the session on Modeling Pediatric Malignancy where Charles presented, "integrative biology of rhabdomysarcoma
using genetic murine models" and attended the Pediatric Preclinical Testing Program working meeting.  The Pediatric Cancer Town Hall meeting is tonight.  
  
A key new presentation from the Raabe lab is tomorrow, "High-level activation of the Notch pathway in diffuse intrinsic pontine glioma" by Hutt et al (A Johns Hopkins - NCI consortium).  Also presented by Dr. Ian Pollack are the promising early results of a DIPG vaccine trial (caveats not withstanding).